Cargando…

Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis

RNA N6-methyladenosine is a key step of posttranscriptional modulation that is involved in governing gene expression. The m(6)A modification catalyzed by Mettl3 has been widely recognized as a critical epigenetic regulation process for tumorigenic properties in various cancer cell lines, including b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ganping, Dai, Yarong, Li, Kang, Cheng, Maosheng, Xiong, Gan, Wang, Xiaochen, Chen, Shuang, Chen, Zhi, Chen, Jianwen, Xu, Xiuyun, Ling, Rong-song, Peng, Liang, Chen, Demeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930389/ https://www.ncbi.nlm.nih.gov/pubmed/33681207 http://dx.doi.org/10.3389/fcell.2021.627706

Ejemplares similares

Corrigendum: Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)

Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma
por: Wang, Xiaochen, et al.
Publicado: (2021)

Sox9-expressing cells promote regeneration after radiation-induced lung injury via the PI3K/AKT pathway
por: Chen, Shuang, et al.
Publicado: (2021)

Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer
por: Song, Xiaodong, et al.
Publicado: (2022)

A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer
por: Guo, Yufeng, et al.
Publicado: (2021)

Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Survivin knockdown alleviates pathological hydrostatic pressure-induced bladder smooth muscle cell dysfunction and BOO-induced bladder remodeling via autophagy
por: Chen, Guo, et al.
Publicado: (2022)

The Origin and Evolution of Bladder Cancer Stem Cells
por: Tan, Jiufeng, et al.
Publicado: (2022)

Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles
por: Xu, Jinshan, et al.
Publicado: (2022)

Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link
por: Nie, Zhenyu, et al.
Publicado: (2021)

Mettl5 mediated 18S rRNA N6-methyladenosine (m(6)A) modification controls stem cell fate determination and neural function
por: Wang, Lu, et al.
Publicado: (2020)

New Prognostic Gene Signature and Immune Escape Mechanisms of Bladder Cancer
por: Jiang, Yi, et al.
Publicado: (2022)

Fibroblast Growth Factor 2 Promotes Bladder Hypertrophy Caused by Partial Bladder Outlet Obstruction
por: Gao, Ye, et al.
Publicado: (2021)

Urinary Markers for Bladder Cancer Diagnosis and Monitoring
por: Jeong, Seung-Hwan, et al.
Publicado: (2022)

Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer
por: Huang, Mengjia, et al.
Publicado: (2021)

Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer
por: Yang, Chen, et al.
Publicado: (2021)

Bmi1 Severs as a Potential Tumor-Initiating Cell Marker and Therapeutic Target in Esophageal Squamous Cell Carcinoma
por: Wang, Xiaochen, et al.
Publicado: (2020)

Role of Long Non-coding RNAs on Bladder Cancer
por: Li, Hui-Jin, et al.
Publicado: (2021)

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
por: Mao, Weipu, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
por: Zhang, Shumei, et al.
Publicado: (2022)

A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer
por: Chen, Xianwu, et al.
Publicado: (2021)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma
por: Wang, Yiru, et al.
Publicado: (2022)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

m7G Methyltransferase METTL1 Promotes Post-ischemic Angiogenesis via Promoting VEGFA mRNA Translation
por: Zhao, Yongchao, et al.
Publicado: (2021)

The Roles of CircRNAs in Bladder Cancer: Biomarkers, Tumorigenesis Drivers, and Therapeutic Targets
por: Cheng, Fajuan, et al.
Publicado: (2021)

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis
por: Lu, Jun-Lin, et al.
Publicado: (2021)

Aberrant translation regulated by METTL1/WDR4‐mediated tRNA N7‐methylguanosine modification drives head and neck squamous cell carcinoma progression
por: Chen, Jie, et al.
Publicado: (2022)

Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
por: Yang, Li, et al.
Publicado: (2021)

Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment
por: Song, Yuxuan, et al.
Publicado: (2022)

Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling
por: Du, YiHeng, et al.
Publicado: (2022)

Multi-Omics Characterization of Circular RNA-Encoded Novel Proteins Associated With Bladder Outlet Obstruction
por: Zhu, Baoyi, et al.
Publicado: (2022)

Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial–Mesenchymal Transition
por: Zou, Jun, et al.
Publicado: (2021)

The RNA Methyltransferase METTL3 Promotes Endothelial Progenitor Cell Angiogenesis in Mandibular Distraction Osteogenesis via the PI3K/AKT Pathway
por: Jiang, Weidong, et al.
Publicado: (2021)

Editorial: Molecular biomarkers and imaging markers in the prediction, diagnosis, and prognosis of bladder cancer
por: Luo, Yongwen, et al.
Publicado: (2022)

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Mettl14 Attenuates Cardiac Ischemia/Reperfusion Injury by Regulating Wnt1/β-Catenin Signaling Pathway
por: Pang, Ping, et al.
Publicado: (2021)

Radiomics of Contrast-Enhanced Computed Tomography: A Potential Biomarker for Pretreatment Prediction of the Response to Bacillus Calmette-Guerin Immunotherapy in Non-Muscle-Invasive Bladder Cancer
por: Ye, Lei, et al.
Publicado: (2022)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6k6nqggp5bm6ka6ev4hmcemk0b